SGRY Surgery Partners Inc
Price (delayed)
$29.97
Market cap
$3.81B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.26
Enterprise value
$6.99B
Surgery Partners is headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high quality, cost effective solutions for
Highlights
SGRY's EPS has soared by 54% YoY
The net income rose by 38% year-on-year
The quick ratio rose by 3.1% QoQ but it fell by 2.2% YoY
SGRY's debt is up by 20% YoY and by 9% QoQ
The equity has declined by 3.3% year-on-year
Key stats
What are the main financial stats of SGRY
Market
Valuations
Earnings
Shares outstanding
127.12M
Market cap
$3.81B
Enterprise value
$6.99B
Price to earnings (P/E)
N/A
Price to book (P/B)
1.95
Price to sales (P/S)
1.31
EV/EBIT
38.41
EV/EBITDA
20.17
EV/Sales
2.42
Revenue
$2.89B
EBIT
$181.9M
EBITDA
$346.4M
Free cash flow
$205.3M
Per share
Balance sheet
Liquidity
EPS
-$0.26
Free cash flow per share
$1.63
Book value per share
$15.36
Revenue per share
$22.9
TBVPS
$20.85
Total assets
$7.49B
Total liabilities
$4.31B
Debt
$3.39B
Equity
$1.95B
Working capital
$460.7M
Debt to equity
1.74
Current ratio
1.83
Quick ratio
1.34
Net debt/EBITDA
9.17
Margins
Efficiency
Dividend
EBITDA margin
12%
Gross margin
24%
Net margin
-1.2%
Operating margin
12.1%
Return on assets
-0.5%
Return on equity
-1.7%
Return on invested capital
3.7%
Return on capital employed
2.6%
Return on sales
6.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SGRY stock price
How has the Surgery Partners stock price performed over time
Intraday
-1.58%
1 week
-3.29%
1 month
2.99%
1 year
-8.91%
YTD
-6.31%
QTD
25.98%
Financial performance
How have Surgery Partners's revenue and profit performed over time
Revenue
$2.89B
Gross profit
$693.9M
Operating income
$350M
Net income
-$33.8M
Gross margin
24%
Net margin
-1.2%
SGRY's net margin is up by 40% YoY
The net income rose by 38% year-on-year
The gross profit has grown by 15% year-on-year and by 3.8% since the previous quarter
The operating income has grown by 11% YoY but it has contracted by 2.6% from the previous quarter
Growth
What is Surgery Partners's growth rate over time
Valuation
What is Surgery Partners stock price valuation
P/E
N/A
P/B
1.95
P/S
1.31
EV/EBIT
38.41
EV/EBITDA
20.17
EV/Sales
2.42
SGRY's EPS has soared by 54% YoY
The stock's price to book (P/B) is 48% less than its 5-year quarterly average of 3.8 but 10% more than its last 4 quarters average of 1.8
The equity has declined by 3.3% year-on-year
The P/S is 11% above the 5-year quarterly average of 1.2 and 2.3% above the last 4 quarters average of 1.3
The revenue has grown by 9% YoY and by 3.4% from the previous quarter
Efficiency
How efficient is Surgery Partners business performance
Surgery Partners's ROE has increased by 43% YoY
SGRY's return on assets is up by 38% year-on-year
SGRY's ROIC is down by 12% from the previous quarter but it is up by 2.8% YoY
SGRY's ROS is down by 11% from the previous quarter
Dividends
What is SGRY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SGRY.
Financial health
How did Surgery Partners financials performed over time
The total assets is 74% greater than the total liabilities
Surgery Partners's total liabilities has increased by 19% YoY and by 10% QoQ
The total assets is up by 13% year-on-year and by 7% since the previous quarter
SGRY's debt is 74% higher than its equity
The debt to equity has grown by 24% YoY and by 9% from the previous quarter
SGRY's debt is up by 20% YoY and by 9% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.